Trials / Completed
CompletedNCT00076323
A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
A New Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (planned)
- Sponsor
- Walter Reed Army Institute of Research (WRAIR) · Federal
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Primaquine |
Timeline
- Start date
- 2003-12-01
- Completion
- 2006-11-01
- First posted
- 2004-01-21
- Last updated
- 2010-07-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00076323. Inclusion in this directory is not an endorsement.